SCHEMBL4103804

SCHEMBL4103804

CC(C)(C)OC(=O)NC1CCN(C(=O)N(Cl)c2ccc(Cl)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP14 P54578 1/20 0.46
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
NAMPT P43490 1/20 0.45
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
STS P08842 1/20 0.43
DRD2 P14416 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
KCNA3 P22001 1/20 0.42
PARP1 P09874 1/20 0.42
CACNB4 O00305 1/20 0.42
CACNA1A O00555 1/20 0.42
CACNA1G O43497 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL646929 0.81 NAMPT (0.64) USP14KMT2AMEN1NAMPTMAPT
SCHEMBL4403545 0.79 NAMPT (0.64) KMT2AMEN1NAMPTCNR1CNR2
SCHEMBL3108407 0.78 CNR1 (0.55) USP14KMT2AMEN1CNR1CNR2
SCHEMBL8259232 0.77 NAMPT (0.54) KMT2AMEN1NAMPTALDH1A1MAPT
SCHEMBL8250635 0.77 USP14 (0.46) USP14KMT2ANAMPTCNR1CNR2
SCHEMBL23332834 0.76 NAMPT (0.53) USP14KMT2AMEN1NAMPTCNR1
SCHEMBL8258408 0.76 USP14 (0.45) USP14KMT2ANAMPTCNR1CNR2
SCHEMBL19705177 0.76 ATF4 (0.71) USP14KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL880503 0.76 CTSK (0.52) KMT2AMEN1NAMPTMAPTKCNA3
SCHEMBL6377029 0.75 NAMPT (0.59) KMT2ANAMPTL3MBTL1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090111791-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111791-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same EPHX1, EPHX2, NCEH1 USP14 846/4885KMT2A 3145/4885MEN1 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.